BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18509856)

  • 1. Congenital diaphragmatic hernia in a first-trimester ultrasound aneuploidy screening program.
    Sepulveda W; Wong AE; Casasbuenas A; Solari A; Alcalde JL
    Prenat Diagn; 2008 Jun; 28(6):531-4. PubMed ID: 18509856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
    Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
    Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies.
    Sepulveda W; Wong AE; Casasbuenas A
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):152-6. PubMed ID: 18985621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome in fetuses with isolated congenital diaphragmatic hernia with increased nuchal translucency thickness in first trimester.
    Spaggiari E; Stirnemann J; Ville Y
    Prenat Diagn; 2012 Mar; 32(3):268-71. PubMed ID: 22430726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
    Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
    Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study.
    McAuliffe FM; Fong KW; Toi A; Chitayat D; Keating S; Johnson JA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1260-5. PubMed ID: 16157148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the importance of second-trimester "soft markers" for trisomy 21 after an 11- to 14-week aneuploidy screening scan?
    Bromley B; Shipp TD; Lyons J; Groszmann Y; Navathe RS; Benacerraf BR
    J Ultrasound Med; 2014 Oct; 33(10):1747-52. PubMed ID: 25253820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy.
    Bromley B; Shipp TD; Lyons J; Navathe RS; Groszmann Y; Benacerraf BR
    J Ultrasound Med; 2014 Oct; 33(10):1737-45. PubMed ID: 25253819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester ultrasound diagnosis of congenital diaphragmatic hernia.
    Daskalakis G; Anastasakis E; Souka A; Manoli A; Koumpis C; Antsaklis A
    J Obstet Gynaecol Res; 2007 Dec; 33(6):870-2. PubMed ID: 18001456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuchal translucency and diaphragmatic hernia. A case report.
    Daniilidis A; Balaouras D; Psarra N; Chitzios D; Tzafettas M; Balaouras G; Vrachnis N
    Clin Exp Obstet Gynecol; 2015; 42(2):237-9. PubMed ID: 26054128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing visualization of the intracranial translucency during first-trimester screening for aneuploidy.
    Beamon CJ; Stuebe AM; Wolfe HM
    Am J Perinatol; 2012 Aug; 29(7):503-8. PubMed ID: 22495902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester screening for structural fetal abnormalities: nuchal translucency sonography.
    Devine PC; Malone FD
    Semin Perinatol; 1999 Oct; 23(5):382-92. PubMed ID: 10551791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for fetal abnormalities with ultrasound.
    Flood K; Malone FD
    Curr Opin Obstet Gynecol; 2008 Apr; 20(2):139-45. PubMed ID: 18388813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester ultrasound assessment of the nasal bone to screen for aneuploidy.
    Rosen T; D'Alton ME; Platt LD; Wapner R;
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):399-404. PubMed ID: 17666617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester detection of structural abnormalities and the role of aneuploidy markers.
    Grande M; Arigita M; Borobio V; Jimenez JM; Fernandez S; Borrell A
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):157-63. PubMed ID: 21845742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone.
    Orlandi F; Rossi C; Orlandi E; Jakil MC; Hallahan TW; Macri VJ; Krantz DA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1107-11. PubMed ID: 15846188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.